EMEA-000309-PIP04-17

Key facts

Invented name
RoActemra
Active substance
tocilizumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0217/2017
PIP number
EMEA-000309-PIP04-17
Pharmaceutical form(s)
Solution for injection (in pre-filled syringe)
Condition(s) / indication(s)
Treatment of systemic sclerosis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Roche Registration Limited
Switzerland
Tel. +41 616879411
E-mail: info.paediatrics@roche.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating